Corey Ritter is a Principal with ARCH Venture Partners, having joined the company as an Associate in 2018. Corey identifies and evaluates new life and physical science technologies, provides operating assistance to early-stage portfolio companies, and is involved in company creation. He helped form and invest in Vizgen and other companies in development. He is a Director at Slingshot Biosciences and a board observer at Vizgen, Quantum Circuits, Inc., and others. He also supported ARCH’s investment in Singleron Biotechnologies and was previously a board observer at 908 Devices (MASS).
Prior to ARCH, Corey contributed business development efforts to several Chicago-based startups. He was also an associate with the University of Chicago Innovation Fund, a seed fund that supports and invests in scientific spinouts from the University of Chicago and Argonne National Lab. Previously, Corey was an active duty officer in the U.S. Army. He holds a B.A. in Astrophysics from Princeton University and completed his M.B.A. at the University of Chicago.